BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25287866)

  • 1. Impact of ozone exposure on the response to glucocorticoid in a mouse model of asthma: involvements of p38 MAPK and MKP-1.
    Bao A; Li F; Zhang M; Chen Y; Zhang P; Zhou X
    Respir Res; 2014 Oct; 15(1):126. PubMed ID: 25287866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvements of p38 MAPK and oxidative stress in the ozone-induced enhancement of AHR and pulmonary inflammation in an allergic asthma model.
    Bao A; Yang H; Ji J; Chen Y; Bao W; Li F; Zhang M; Zhou X; Li Q; Ben S
    Respir Res; 2017 Dec; 18(1):216. PubMed ID: 29284473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of p38 mitogen-activated protein kinase in ovalbumin and ozone-induced mouse model of asthma.
    Liang L; Li F; Bao A; Zhang M; Chung KF; Zhou X
    Respirology; 2013 Nov; 18 Suppl 3():20-9. PubMed ID: 24188200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma.
    Zhang Y; Li X; He M; Zhang G; Bao W; Fei X; Zhang X; Zhang M; Zhang P
    Biomed Pharmacother; 2019 Jun; 114():108786. PubMed ID: 30917335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NF-kappaB-dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK.
    King EM; Holden NS; Gong W; Rider CF; Newton R
    J Biol Chem; 2009 Sep; 284(39):26803-15. PubMed ID: 19648110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids.
    Li F; Zhang M; Hussain F; Triantaphyllopoulos K; Clark AR; Bhavsar PK; Zhou X; Chung KF
    Eur Respir J; 2011 Apr; 37(4):933-42. PubMed ID: 20693246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A Monoclonal Antibody Partly Reverses the Glucocorticoids Insensitivity in Mice Exposed to Ozonec.
    Fei X; Zhang PY; Zhang X; Zhang GQ; Bao WP; Zhang YY; Zhang M; Zhou X
    Inflammation; 2017 Jun; 40(3):788-797. PubMed ID: 28194607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Glucocorticoid-Induced Transcript 1 Gene Deficiency on Glucocorticoid Activation in Asthmatic Mice.
    Hu CP; Xun QF; Li XZ; Hu XY; Qin L; He RX; Feng JT
    Chin Med J (Engl); 2018 Dec; 131(23):2817-2826. PubMed ID: 30511684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mitogen-activated protein kinase phosphatase-1 in corticosteroid insensitivity of chronic oxidant lung injury.
    Pinart M; Hussain F; Shirali S; Li F; Zhu J; Clark AR; Ammit AJ; Chung KF
    Eur J Pharmacol; 2014 Dec; 744():108-14. PubMed ID: 25310910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38.
    Lasa M; Abraham SM; Boucheron C; Saklatvala J; Clark AR
    Mol Cell Biol; 2002 Nov; 22(22):7802-11. PubMed ID: 12391149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids.
    Toh ML; Yang Y; Leech M; Santos L; Morand EF
    Arthritis Rheum; 2004 Oct; 50(10):3118-28. PubMed ID: 15476200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
    Bazuine M; Carlotti F; Tafrechi RS; Hoeben RC; Maassen JA
    Mol Endocrinol; 2004 Jul; 18(7):1697-707. PubMed ID: 15184525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1.
    Quante T; Ng YC; Ramsay EE; Henness S; Allen JC; Parmentier J; Ge Q; Ammit AJ
    Am J Respir Cell Mol Biol; 2008 Aug; 39(2):208-17. PubMed ID: 18314542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid-Induced MKP-1 Represses Pro-Inflammatory Cytokine Secretion by Enhancing Activity of Tristetraprolin (TTP) in ASM Cells.
    Prabhala P; Bunge K; Ge Q; Ammit AJ
    J Cell Physiol; 2016 Oct; 231(10):2153-8. PubMed ID: 26825339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation.
    Kim JM; Im YN; Chung YJ; Youm JH; Im SY; Han MK; Lee HK
    Allergy; 2022 Apr; 77(4):1180-1191. PubMed ID: 34601745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms.
    Dauletbaev N; Eklove D; Mawji N; Iskandar M; Di Marco S; Gallouzi IE; Lands LC
    J Biol Chem; 2011 May; 286(18):15998-6007. PubMed ID: 21454676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells.
    Che W; Manetsch M; Quante T; Rahman MM; Patel BS; Ge Q; Ammit AJ
    Biochim Biophys Acta; 2012 Oct; 1823(10):1658-65. PubMed ID: 22743041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of cytokine production by glucocorticoids is mediated by MKP-1 in human lung epithelial cells.
    Keränen T; Moilanen E; Korhonen R
    Inflamm Res; 2017 May; 66(5):441-449. PubMed ID: 28299397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ozone repeated short exposures on the airway/lung inflammation, airway hyperresponsiveness and mucus production in a mouse model of ovalbumin-induced asthma.
    Bao W; Zhang Y; Zhang M; Bao A; Fei X; Zhang X; Zhou X
    Biomed Pharmacother; 2018 May; 101():293-303. PubMed ID: 29499403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
    Horsch K; de Wet H; Schuurmans MM; Allie-Reid F; Cato AC; Cunningham J; Burrin JM; Hough FS; Hulley PA
    Mol Endocrinol; 2007 Dec; 21(12):2929-40. PubMed ID: 17761948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.